Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$550,314
-$73,064 QoQ
Shares Held
77,728
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#55
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $10,194,826 across 8 Drug Manufacturers - General names. GRFS ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
548,700 | $7,429,398 | |
| 2 | PFE |
Pfizer Inc
|
25,000 | $602,000 | |
| 3 | GRFS |
Grifols SA
This page
|
77,728 | $550,314 | |
| 4 | LLY |
ELI LILLY & Co
|
350 | $419,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,700 | $346,950 | |
| 6 | ABBV |
AbbVie Inc.
|
1,350 | $339,714 | |
| 7 | JNJ |
Johnson & Johnson
|
1,000 | $253,970 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,000 | $252,680 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $550,314 | 77,728 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $623,378 | 77,728 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $726,756 | 77,728 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $774,170 | 77,728 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $702,661 | 77,728 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $552,646 | 77,728 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $578,296 | 77,728 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $690,224 | 77,728 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $123,398 | 19,556 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $130,634 | 19,556 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,478,593 | 127,906 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,169,060 | 127,906 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,171,618 | 127,906 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $942,667 | 127,906 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,087,201 | 127,906 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $815,004 | 132,306 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,571,795 | 132,306 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,545,334 | 132,306 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $1,937,264 | 172,508 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,520,341 | 172,508 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,993,013 | 172,508 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,543,066 | 204,920 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,076,422 | 329,524 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,557,621 | 320,324 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $5,453,231 | 298,971 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,061,457 | 400,271 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||